Ready, an on-demand service that provides medical care to patients at their homes, has raised $54M Series C from investors including GV
Andrew Donlan / Home Health Care News :
Context & Ripple Effects
Ready's Series C lands three months after DispatchHealth raised roughly $136M to expand app-requested in-home care across 19 cities, confirming that investors see on-demand house-call medicine as a fundable category rather than a one-off experiment. The model itself dates back further — Heal raised a $26.9M Series A back in 2016 for California doctor house calls — but the 2020 round pace suggests the category is entering its capital-intensive scaling phase.
GV's participation is a tell: the firm also backed PatientPing's $60M Series C for care-coordination notifications just weeks before this round, positioning it on both sides of the home-care stack — the delivery of care at home and the provider plumbing that tracks patients between settings.
First-order effects
- Ready gains the capital to compete head-on with DispatchHealth in app-requested acute in-home care, turning what was a regional house-call niche into a two-horse platform race.
- GV now holds positions in adjacent layers of the same workflow through Ready and PatientPing, giving it portfolio leverage over how home-treated patients flow back into health-system records.
Second-order effects
- Earlier entrants like Heal face pressure to either raise at similar scale or cede the national expansion race to better-capitalized rivals, since house-call economics reward density of coverage.
- Health systems and payers gain multiple competing bids for in-home care contracts, strengthening their negotiating position as platforms like Ready and DispatchHealth court them for referral volume.
Third-order effects
- If follow-on rounds like K Health's $132M raise and Current Health's remote-care platform funding keep landing, home-based care consolidates from scattered local providers into venture-backed platforms that own patient intake, delivery, and coordination — with payers as the ultimate customers.
- The eventual winners will likely be determined less by clinical delivery than by who controls the coordination layer connecting hospitals, home suppliers, and payers — the position Tomorrow Health's marketplace model targets directly.
The trend: Venture capital is systematically re-platforming acute and primary care out of facilities and into the home, with generalist firms like GV building cross-layer positions across delivery and coordination.